[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340014-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340014-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","spred3-regulates-the-nf-b-signaling-pathway-in-thyroid-cancer-and-promotes-the-proliferation","SPRED3 regulates the NF-κB signaling pathway in thyroid cancer and promotes the proliferation","","SPRED3 mutants are implicated in several cancers, but their function in thyroid cancer (THCA) remained unclear. Bioinformatic analyses assessed SPRED3 expression and its prognostic value in THCA. Flag-tagged overexpression and SPRED3 knockout models were used to manipulate SPRED3 levels in THCA cells, followed by colony formation and CCK8 assays. SPRED3 high expression correlated with poor outcomes, advanced features, and altered immune microenvironment scores and infiltration. Mechanistically, SPRED3 activated NF-κB signaling, enhancing THCA viability and proliferation in vitro and suppressing tumor growth in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/spred3-regulates-the-nf-b-signaling-pathway-in-thyroid-cancer-and-promotes-the-proliferation/340014/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/spred3-regulates-the-nf-b-signaling-pathway-in-thyroid-cancer-and-promotes-the-proliferation/340014.png","ImageObject",300,407,{"name":42,"@type":43},"Levi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was SPRED3 expression evaluated in thyroid cancer patients?","Question",{"text":63,"@type":64},"SPRED3 expression was analyzed using TCGA pan-cancer tissues and TCGA normal tissues, with additional analysis in THCA tissues versus normal tissues and data such as GSE33630.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What experimental approaches were used to test SPRED3 function in THCA cells?",{"text":68,"@type":64},"Flag-SPRED3 plasmids and SPRED3 knockout vectors were used to overexpress or deplete SPRED3 in THCA cells. Colony formation and CCK8 assays evaluated effects on cell proliferation.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism links SPRED3 to THCA progression?",{"text":72,"@type":64},"SPRED3 activated NF-κB signaling. SPRED3 overexpression enhanced THCA viability and colony formation, while depletion reduced growth and proliferation, confirmed by in vivo tumor growth effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340014,1790880571,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nSPRED3 regulates the NF‑κB signaling pathway in thyroid cancer and promotes the proliferation  \nZhiping Chen, Congren Wang, Mingzhu Li, Shaoyang Cai & Xiaoyu Liu *  \nSPRED3 (Sprouty‑related EVH1 domain containing 3) mutants are depicted in various cancers, however, nothing is known about its biofunction in thyroid cancer (THCA) . Bioinformatic analyses were conducted to ascertain the level of SPRED3 expression in THCAtissues and its importance in the prognosis of THCA patients. Flag‑SPRED3 plasmid and SPRED3‑knockout vector were developed to overexpress or deplete the SPRED3 expression in THCA cells. The function of SPRED3 on THCA cell proliferation was examined using the colony formation assay and CCK8 assay. The effect of SPRED3 expression on the transcriptional activity of NF‑κB was also examined using luciferase reporter assays. High SPRED3 expression was associated with unfavorable clinical outcomes, advanced tumor characteristics, and traditional molecular markers of papillary thyroid cancer in THCA patients. Genetic analysis revealed differences in mutation rates in key genes between SPRED3‑high and SPRED3‑low THCA cases. It is also revealed that SPRED3 influenced the immune microenvironment, with increased stromal and immune scores and altered immune cell infiltration. Functionally, SPRED3 overexpression enhanced THCA cell viability and colony formation, while its depletion reduced cell growth and proliferation. In vivo experiments in mice confirmed the inhibitory effect of SPRED3 depletion on tumor growth. Mechanically, we found that SPRED3 activated the NF‑κB signaling. For the first time, we found that SPRED3 promotes THCA cell proliferation via the NF‑κB signaling pathway. This finding may provide insight into SPRED3’s prognostic potential in thyroid cancer and provide the rationale for SPRED3‑targeted druggable interventions.  \nKeywords SPRED3, Thyroid cancer, NF-κB, Proliferation, Prognosis  \nThyroid cancer (THCA) represents a common malignancy within the endocrine system. Over the past few decades, the incidence of THCA has increased more than fourfold1. Currently, THCA affects 586,000 individuals globally, ranking it as the ninth most prevalent form of cancer2. Conventional surgical thyroidectomy and relative targeted therapies have yielded favorable outcomes, with a 99% 5-year survival rate for THCA patients3. Nonetheless, these treatments have exhibited limited clinical benefits for aggressive THCA cases4. Thus, addressing these challenges necessitates a comprehensive understanding of the underlying mechanisms involved in THCA pathogenesis.  \nThe Sprouty-related EVH1 domain containing 3 (SPRED3), also known as Eve-3 and spred-3, is characterized by the presence of a C-terminal Sprouty-like cysteine-rich domain (SRY) and an N-terminal Ena/Vasodilatorstimulated phosphoprotein (VASP) homology-1 (EVH-1) domain. Belonging to the Sprouty-related protein family, SPRED3 negatively regulates the MAPK (mitogen-activated protein kinase) pathway5. Notably, the SPRED3 protein facilitates protein kinase binding, potentially impeding the activation ofthe Ras/MAPK cascade6. Studies have identified multiple SPRED3 mutations in cervical carcinoma and glioblastoma7. Moreover, aberrant methylation of SPRED3 has prognostic implications for neuroblastoma patients8. Furthermore, bioinformatics analysis has revealed SPRED3 to be a downstream transcription factor ofthe WNT signaling pathway, which is well-documented for its oncogenic role in various cancers9. However, the specific role of SPRED3 in THCA remains elusive.  \nThe nuclear factor-κB (NF-κB) transcription factor governs cell fate by regulating the transcription of numerous genes10, 11. Sustained constitutive activation of NF-κB promotes oncogenesis, tumor progression, and metastasis 12, 13. Abnormally high NF-κB activity is ubiquitously found in different cancers, acting as clinical hallmarks of","cbCaicyooNAzHJXu","https://ap.wps.com/l/cbCaicyooNAzHJXu","pdf",13345643,14,"English","# Introduction\n# Results\n## SPRED3 upregulation in THCA predicts an unfavorable clinical outcome\n# Methods and Investigation\n## SPRED3 expression analysis and functional assays","[{\"question\":\"How was SPRED3 expression evaluated in thyroid cancer patients?\",\"answer\":\"SPRED3 expression was analyzed using TCGA pan-cancer tissues and TCGA normal tissues, with additional analysis in THCA tissues versus normal tissues and data such as GSE33630.\"},{\"question\":\"What experimental approaches were used to test SPRED3 function in THCA cells?\",\"answer\":\"Flag-SPRED3 plasmids and SPRED3 knockout vectors were used to overexpress or deplete SPRED3 in THCA cells. Colony formation and CCK8 assays evaluated effects on cell proliferation.\"},{\"question\":\"What mechanism links SPRED3 to THCA progression?\",\"answer\":\"SPRED3 activated NF-κB signaling. SPRED3 overexpression enhanced THCA viability and colony formation, while depletion reduced growth and proliferation, confirmed by in vivo tumor growth effects.\"}]","SPRED3 regulates the NF-κB signaling pathway in thyroid cancer and promotes the proliferation | PDF",1790033747,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/492171d1d77d4c1c5c887cdd2bc87f67.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cba17ba6008daeae9a8a2b6c0cc751ae.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0f594a67f22a02270109fd61f473b567.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49e9005f76092d4c9a35126ff51a26f7.webp",980,1287]